Clinicopathological factors influencing the number of stages of Mohs surgery for basal cell carcinoma
Open Access
- 2 April 2022
- journal article
- research article
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 97 (3) , 291-297
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Key characteristics of basal cell carcinoma with large subclinical extensionJournal of the European Academy of Dermatology and Venereology, 2019
- A Population-Level Comparison of Cancer-Related and Non-Cancer-Related Health Care Costs Using Publicly Available Provincial Administrative DataCurrent Oncology, 2019
- Patient Indications for Mohs Micrographic Surgery: A Clinical Practice GuidelineCurrent Oncology, 2019
- Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network, 2016
- Suggested Excisional Margins for Cutaneous Malignant Lesions Based on Mohs Micrographic SurgeryJAMA Facial Plastic Surgery, 2013
- Mohs micrographic surgery: a study of 83 casesAnais Brasileiros de Dermatologia, 2012
- Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literatureBritish Journal of Dermatology, 2004
- Predictors of Extensive Subclinical Spread in Nonmelanoma Skin Cancer Treated With Mohs Micrographic SurgeryArchives of Dermatology, 2002
- Correlation of histologic subtypes of primary basal cell carcinoma and number of Mohs stages required to achieve a tumor-free planeJournal of the American Academy of Dermatology, 1997
- Pitfalls of Mohs micrographic surgeryJournal of the American Academy of Dermatology, 1990